Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: Distinct roles of perforin and Fas ligand

Biology of Blood and Marrow Transplantation

Volumn 10, Issue 3, 2004, Pages 156-170

  Miura, Yuji ^a   Thoburn, Christopher J ^a   Bright, Emilie C ^a   Hess, Allan D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Autologous GVHD; Fas ligand; IFN ; Perforin; TNF

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FAS LIGAND; GAMMA INTERFERON; GRANZYME A; GRANZYME B; INTERLEUKIN 18; MESSENGER RNA; PERFORIN; RECOMBINANT GAMMA INTERFERON; THIOTEPA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BREAST CANCER; CELL MEDIATED LYMPHOLYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOREGULATION; LYMPHOCYTOTOXICITY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA SEQUENCE; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS; UPREGULATION;

ADOLESCENT; ADULT; AGED; BONE MARROW TRANSPLANTATION; BREAST NEOPLASMS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYCLOSPORINE; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; FEMALE; GENE EXPRESSION REGULATION; GRAFT VS HOST DISEASE; GRANZYMES; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PORE FORMING CYTOTOXIC PROTEINS; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, AUTOLOGOUS;

EID: 1342266385     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2003.10.005     Document Type: Article

References (57)

1. Glazier A. Tutschka P.J. Farmer E.R. Santos G.W. Graft-versus-host disease in cyclosporine treated rats after syngeneic autologous bone marrow reconstitution J Exp Med. 158 1983 1-8
2. Hess A.D. Horwitz L. Beschorner W.E. Santos G.W. Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity J Exp Med. 161 1985 718-730
3. Fischer A.C. Beschorner W.E. Hess A.D. Requirements for the induction and adoptive transfer of cyclosporine-induced syngeneic graft-versus-host disease J Exp Med. 169 1989 1031-1041
4. + T lymphocyte subsets J Immunol. 145 1990 526-533
5. Vogelsang G.B. Hess A.D. Graft-versus-host disease: new directions for a persistent problem Blood 84 1994 2061-2067
6. Hess A.D. Thoburn C.J. Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-versus-host disease Immunol Rev. 157 1997 111-123
7. Miura Y. Thoburn C.J. Bright E.C. et al. Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD Blood 98 2001 868-876
8. Yeager A.M. Vogelsang G.B. Jones R.J. et al. Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia Blood 79 1992 3031-3035
9. Vogelsang G. Bitton R. Piantadosi S. et al. Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial Bone Marrow Transplant 24 1999 637-640
10. Marin G.H. Porto A. Prates V. et al. Graft versus host disease in autologous stem cell transplantation J Exp Clin Cancer Res. 18 1999 201-208
11. Miura Y. Ueda M. Zeng W. et al. Induction of autologous graft-versus-host disease with cyclosporine A after peripheral blood stem cell transplantation: analysis of factors affecting induction J Allergy Clin Immunol. 106 2000 51-57
12. Geller R.B. Esa A.H. Beschorner W.E. Frondoza C.G. Santos G.W. Hess A.D. Successful in vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat Blood 74 1989 1165-1171
13. Hess A.D. Bright E.C. Thoburn C. Vogelsang G.B. Jones R.J. Kennedy M.J. Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptide Blood 89 1997 2203-2209
14. Hess A.D. Thoburn C. Horwitz L. Promiscuous recognition of major histocompatibility complex class II determinants in cyclosporine-induced syngeneic graft-versus-host disease : specificity of cytolytic effector T cells Transplantation 65 1998 785-792
15. Flanagan D.L. Jennings C.D. Bryson J.S. Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease J Immunol. 163 1999 1170-1177
16. Miura Y. Thoburn C.J. Bright E.C. Chen W. Nakao S. Hess A.D. Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin-10 and interferon-gamma may be critical mediators in the development of autologous GVHD Blood 100 2002 2650-2658
17. Kagi D. Vignaux F. Ledermann B. et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity Science 265 1994 528-530
18. Lowin B. Hahne M. Mattmann C. Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways Nature 370 1994 650-652
19. Shresta S. Pham C.T. Thomas D.A. Graubert T.A. Ley T.J. How do cytotoxic lymphocytes kill their targets? Curr Opin Immunol. 10 1998 581-587
20. Nagata S. Apoptosis by death factor Cell 88 1997 355-365
21. Braun M.Y. Lowin B. French L. Acha-Orbea H. Tschopp J. Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease J Exp Med. 183 1996 657-661
22. Baker M.B. Riley R.L. Podack E.R. Levy R.B. Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function Proc Natl Acad Sci U S A 94 1997 1366-1371
23. Graubert T.A. DiPersio J.F. Russell J.H. Ley T.J. Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation J Clin Invest. 100 1997 904-911
24. + T cells each can utilize a perforin-dependent pathway to mediate lethal graft-versus-host disease in major histocompatibility complex-disparate recipients Transplantation 64 1997 571-576
25. Tsukada N. Kobata T. Aizawa Y. Yagita H. Okumura K. Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation Blood 93 1999 2738-2747
26. Schmaltz C. Alpdogan O. Horndasch K.J. et al. Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect Blood 97 2001 2886-2895
27. Jiang Z. Podack E. Levy R.B. Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4(+) donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenesis Blood 98 2001 390-397
28. van der Wall E. Horn T. Bright E. et al. Autologous graft-versus-host disease induction in advanced breast cancer : role of peripheral blood progenitor cells Br J Cancer 83 2000 1405-1411
29. Dolei A. Capobianchi M.R. Ameglio F. Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta Infect Immun. 40 1983 172-176
30. Noga S.J. Horwitz L. Kim H. Laulis M.K. Hess A.D. Interferon-gamma potentiates the antitumor effect of cyclosporine-induced autoimmunity J Hematother. 1 1992 75-84
31. Bernard D. Maurizis J.C. Ruse F. et al. Presence of HLA-D/DR antigens on the membrane of breast tumour cells Clin Exp Immunol. 56 1984 215-221
32. Natali P.G. Giacomini P. Bigotti A. et al. Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells Cancer Res. 43 1983 660-668
33. Chirgwin J.M. Przybyla A.E. MacDonald R.J. Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease Biochemistry 18 1979 5294-5299
34. Fischer A.C. Ruvolo P.P. Burt R. et al. Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression J Immunol. 154 1995 3713-3725
35. Heid C.A. Stevens J. Livak K.J. Williams P.M. Real time quantitative PCR Genome Res. 6 1996 986-994
36. Cooper M.A. Fehniger T.A. Turner S.C. et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset Blood 97 2001 3146-3151
37. Hess A.D. Thoburn C.J. Chen W. Horwitz L. Complexity of effector mechanisms in cyclosporine-induced syngeneic graft-versus-host disease Biol Blood Marrow Transplant 6 2000 13-24
38. Kappler J.W. Roehm N. Marrack P. T cell tolerance by clonal elimination in the thymus Cell 49 1987 273-280
39. Aguilar L.K. Aguilar-Cordova E. Cartwright Jr J. Belmont J.W. Thymic nurse cells are sites of thymocyte apoptosis J Immunol. 152 1994 2645-2651
40. Jenkins M.K. Schwartz R.H. Pardoll D.M. Effects of cyclosporine A on T cell development and clonal deletion Science 241 1988 1655-1658
41. Gao E.K. Lo D. Cheney R. Kanagawa O. Sprent J. Abnormal differentiation of thymocytes in mice treated with cyclosporin A Nature 336 1988 176-179
42. Piguet P.F. Grau G.E. Allet B. Vassalli P. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease J Exp Med. 166 1987 1280-1289
43. Via C.S. Shustov A. Rus V. Lang T. Nguyen P. Finkelman F.D. In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL J Immunol. 167 2001 6821-6826
44. Wherry J.C. Schreiber R.D. Unanue E.R. Regulation of interferon production by natural killer cells in SCID mice: roles of tumor necrosis factor and bacterial stimuli Infect Immun. 59 1991 1709-1715
45. Bancroft G.J. Sheehan K.C. Schreiber R.D. Unanue E.R. Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in SCID mice J Immunol. 143 1989 127-130
46. Tsutsui H. Nakanishi K. Matsui K. et al. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones J Immunol. 157 1996 3967-3973
47. Dao T. Ohashi K. Kayano T. Kurimoto M. Okamura H. Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells Cell Immunol. 173 1996 230-235
48. Fischer A.C. Laulis M.K. Horwitz L. Beschorner W.E. Hess A. Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets J Immunol. 143 1989 827-832
49. + cells Bone Marrow Transplant 32 2003 785-790
50. Hess A. Horwitz L. Thoburn C. Immune tolerance to self-MHC class II antigens after bone marrow transplantation Transplant Proc. 31 1999 688-689
51. + subset of recent thymic emigrants J Immunol. 166 2001 7158-7164
52. Okamura H. Tsutsi H. Komatsu T. et al. Cloning of a new cytokine that induces IFN-gamma production by T cells Nature 378 1995 88-91
53. Okamura H. Tsutsui H. Kashiwamura S. Yoshimoto T. Nakanishi K. Interleukin-18: a novel cytokine that augments both innate and acquired immunity Adv Immunol 70 1998 281-312
54. Reddy P. Teshima T. Kukuruga M. et al. Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis J Exp Med. 194 2001 1433-1440
55. Kelly J.M. Darcy P.K. Markby J.L. et al. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection Nat Immunol. 3 2002 83-90
56. Smyth M.J. Thia K.Y. Cretney E. et al. Perforin is a major contributor to NK cell control of tumor metastasis J Immunol. 162 1999 6658-6662
57. Ahn H.J. Maruo S. Tomura M. et al. A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma J Immunol. 159 1997 2125-2131